BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15021932)

  • 21. [Your patient needs antithrombotics: leg venous thrombosis : how to proceed?].
    MMW Fortschr Med; 2014 Mar; 156(4):28. PubMed ID: 24908764
    [No Abstract]   [Full Text] [Related]  

  • 22. Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease.
    Reagin H; Marks E; Weis S; Susa J
    Am J Dermatopathol; 2018 Sep; 40(9):682-685. PubMed ID: 29533274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
    Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
    Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [What was your diagnosis at first glance... livedoid vasculopathy].
    Hirschel V
    Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1439. PubMed ID: 23986912
    [No Abstract]   [Full Text] [Related]  

  • 25. Necrotic cutaneous vasculitic skin lesions: a case of atypical Henoch-Schönlein purpura in a child with heterozygosity for factor V Leiden.
    Dhanjal S; Saso A; Eleftheriou D; Laurent S
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536112
    [No Abstract]   [Full Text] [Related]  

  • 26. A case of widespread livedoid vasculopathy with pain but no systemic symptoms.
    Okada E; Nagai Y; Ishikawa O
    Acta Derm Venereol; 2008; 88(3):298-9. PubMed ID: 18480943
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous necrosis revealing the coexistence of an antiphospholipid syndrome with acquired protein S deficiency, factor V Leiden and hyperhomocysteinemia.
    Combemale P; Amiral J; Estival JL; Dupin M; Chouvet B; Berruyer M
    Eur J Dermatol; 2002; 12(3):278-82. PubMed ID: 11978573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Livedoid vasculopathy associated with heterozygous protein C deficiency.
    Boyvat A; Kundakçi N; Babikir MO; Gürgey E
    Br J Dermatol; 2000 Oct; 143(4):840-2. PubMed ID: 11069468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Livedoid vasculopathy (LV) associated with sticky platelets syndrome type 3 (SPS type 3) and enhanced activity of plasminogen activator inhibitor (PAI-1) anomalies.
    Castillo-Martínez C; Moncada B; Valdés-Rodríguez R; González FJ
    Int J Dermatol; 2014 Dec; 53(12):1495-7. PubMed ID: 25131360
    [No Abstract]   [Full Text] [Related]  

  • 30. Livedoid vasculopathy: further evidence for procoagulant pathogenesis.
    Hairston BR; Davis MD; Pittelkow MR; Ahmed I
    Arch Dermatol; 2006 Nov; 142(11):1413-8. PubMed ID: 17116831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor V Leiden mutation-related chronic skin ulcers.
    Kayatas K; Cebeci F; Karatoprak C; Benzer M; Demirtunç R; Demirkesen C
    Int J Low Extrem Wounds; 2013 Mar; 12(1):35-8. PubMed ID: 23446370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unilateral livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders.
    Criado PR; Alavi A; Halpern I; Sotto MN; Kirsner RS
    Int J Low Extrem Wounds; 2013 Dec; 12(4):306-9. PubMed ID: 24043683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Livedo racemosa with ulcerations. Cyclic therapy with iloprost infusions].
    Mittag M; Beckheinrich P; Haustein UF
    Hautarzt; 2001 Oct; 52(10):899-902. PubMed ID: 17690823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.
    Osada S; Kimura Y; Kawana S
    J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Livedoid vasculiltis associated with a double heterozygous Factor V Leiden and prothrombin G20210A gene mutations.
    Khenifer S; Thomas L; Balme B; Dalle S
    Clin Exp Dermatol; 2009 Dec; 34(8):e811-3. PubMed ID: 19793098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin induced thrombocytopenia in a patient with factor V Leiden following cardiac surgery.
    Chaubey S; Davidson SJ; Desouza AC
    Interact Cardiovasc Thorac Surg; 2009 Dec; 9(6):1023-5. PubMed ID: 19783545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of nonarteritic anterior ischemic optic neuropathy associated with coexisting primary antiphospholipid syndrome and Factor V Leiden mutation.
    Srinivasan S; Fern A; Watson WH; McColl MD
    Am J Ophthalmol; 2001 May; 131(5):671-3. PubMed ID: 11336954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of livedoid vasculopathy in a 22-year-old man.
    Leonard A; Pomeranz MK; Franks AG
    J Drugs Dermatol; 2004; 3(6):678-9. PubMed ID: 15624752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy.
    Furukawa F; Mizawa M; Makino T; Shimizu T
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28739563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent ulcerations on both legs since early childhood due to a factor V gene mutation.
    Hackenjos K; Bek M; Schöpf E; Vanscheidt W
    Dermatology; 1997; 194(3):297-8. PubMed ID: 9187855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.